Starling Oncology, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Starling Oncology, Inc. payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00.
- Starling Oncology, Inc. payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. payments for repurchase of common stock for the quarter ending 2023-12-31 was $0.00.
- Starling Oncology, Inc. payments for repurchase of common stock for the quarter ending 2023-09-30 was $125.00K.
- Starling Oncology, Inc. payments for repurchase of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Starling Oncology, Inc. payments for repurchase of common stock for fiscal 2023 was $1.02M, a 88.68% decline from fiscal 2022.
- Starling Oncology, Inc. payments for repurchase of common stock for fiscal 2022 was $9.00M.
- Starling Oncology, Inc. payments for repurchase of common stock for fiscal 2021 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 10-K · filed 2025-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $1.02M 10-K · filed 2025-03-26 |
| 2023-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $9.00M 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | |
| 2022-06-30 | $9.00M 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 |